Intel , Leveraging Rebates and the Goals Of
نویسنده
چکیده
This paper reviews the 2014 Intel judgment of the General Court of the EU in relation to exclusivity rebates given by dominant firms. It distinguishes between the positive issue – ie the legal standard currently applicable to the assessment of dominant firms' rebates – and the prospective discussion – ie the legal standard that should optimally apply to dominant firms’ rebates. On the positive debate, the paper argues that Intel affirms a modified per se prohibition rule against dominant firms' exclusivity rebates. The scope of this standard is confined to leveraging rebates, and does not cover non-leveraging rebates, which must be analysed under the rule of reason. The paper also draws a distinction between exclusivity obligations and exclusivity options for which agencies and courts should undertake more economic analysis. On the prospective debate, the paper starts from the assumption made by several scholars that Intel endorses a non-welfarist view of the goals of Article 102 TFEU. With this background, it questions which non-welfarist alternative goal can be ascribed to Article 102 TFEU. The paper finds that none of the three classic nonwelfarist goals (ie competitive process, consumer choice and raising rivals' costs) can be acclimated in modern EU competition law.
منابع مشابه
Leveraging Engaged Parties in SIP Domains of eTOM Framework by using ITSM Reference Model
the telecommunications industry plays an important role in providing ICT services to a wide range of customers. In addition to individual customers, corporate customers also are user of these services and have an important role to make return on investment for telecom companies (Telcos). Therefore, this group of customers should not be ignored by any reason. This is where the Telecom Companies ...
متن کاملPremium Rebates and the Quiet Consensus on Market Reform for Medicare
Premium rebates allow beneficiaries who choose more efficient Medicare options to receive cash rebates, rather than extra benefits. That simple idea has been controversial. Without fanfare, however, premium rebates have become a key area of agreement in the debate on Medicare reform. Moreover, in legislation in late 2000, it became official policy: Medicare+Choice (M+C) plans will be allowed to...
متن کاملStudy on Incentives for Glaucoma Medication Adherence (SIGMA): study protocol for a randomized controlled trial to increase glaucoma medication adherence using value pricing
BACKGROUND Many glaucoma patients do not adhere to their medication regimens because they fail to internalize the (health) costs of non-adherence, which may not occur until years or decades later. Behavioural economic theory suggests that adherence rates can be improved by offering patients a near-term benefit. Our proposed strategy is to offer adherence-contingent rebates on medication and che...
متن کاملA Non-Price-Discrimination Theory of Rebates∗
According to the conventional theory, rebates are but one of many ways to price discriminate among consumers. The firm sells at the shelf price to those willing to pay more for the product and at a lower, rebated price, to those willing to pay less, achieving the necessary separation by relying on the higher costs of redeeming rebates of high willingness-to-pay consumers. This theory, however, ...
متن کامل